Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication or stop therapy altogether. But now, scientists have discovered two genetic alterations linked to a benign enzyme condition that keep some patients anemia-free.
Enzyme deficiency protects hepatitis C patients from treatment-related anemia
March 14th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.